J Gerontol Biol Sci Med Sci
Intestinal infection triggers Parkinsons disease-like symptoms in Pink1(-/-) mice
Opportunity Pathways - GLP-1 Diabetes Treatment Drugs Market The GLP-1 diabetes treatment drugs market represents one of the most explosive pharmaceutical opportunities of the decade, with the market projected to surge from USD 6,556.5 million in 2025 to USD 62,543.2 million by 2035 at an extraordinary 25.3% CAGRa 9.5X expansion driven by the global diabetes epidemic, breakthrough efficacy data, and expanding therapeutic applications beyond glucose control to include weight management and cardiovascular protection
Anti-obesity medication (AOM) prescribing increased slightly in December 2024 compared to September 2024 (+6.98%)
Although deficiencies in L-Carnitine are rare in healthy, well-nourished people who consume adequate amounts of animal protein, many vegetarians (particularly vegans, or pure or strict vegetarians) become deficient to some degree
Patients are advised to avoid anti-inflammatory medications around the time of injections to allow the intended inflammatory-healing process to occur
.webp)
